73 related articles for article (PubMed ID: 38312186)
1. Comprehensively analyze the expression and prognostic role for ten-eleven translocations (TETs) in acute myeloid leukemia.
Huang Y; Wei J; Huang X; Zhou W; Xu Y; Deng DH; Cheng P
Transl Cancer Res; 2020 Nov; 9(11):7259-7283. PubMed ID: 35117329
[TBL] [Abstract][Full Text] [Related]
2. The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review.
Da W; Song Z; Liu X; Wang Y; Wang S; Ma J
Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38598002
[TBL] [Abstract][Full Text] [Related]
3. Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.
De Coninck S; Roels J; Lintermans B; T'Sas S; Taghon T; Curtis DJ; Pieters T; Goossens S; Van Vlierberghe P
Blood Adv; 2024 Jun; 8(11):2646-2649. PubMed ID: 38536906
[No Abstract] [Full Text] [Related]
4. Acute myeloid leukaemia: recent data on prognostic gene mutations, in relation to stratified therapies for elderly patients.
Soura EN; Karikas GA
J BUON; 2019; 24(4):1326-1339. PubMed ID: 31646775
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
6. Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML Pathogenesis.
Ghasemi B; Ahmadi J; Zaker F; Tabatabaei T; Kiani-Zadeh M; Kazemi A
Indian J Hematol Blood Transfus; 2024 Jan; 40(1):52-60. PubMed ID: 38312186
[TBL] [Abstract][Full Text] [Related]
7. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study of Aberrant CpG Island Hypermethylation of
Sun J; Zhang J; Wang Y; Li Y; Zhang R
Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
[No Abstract] [Full Text] [Related]
9. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
[TBL] [Abstract][Full Text] [Related]
10. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients.
Rostami S; Nadali F; Alibakhshi R; Zaker F; Nasiri N; Payandeh M; Chahardouli B; Maleki A
Int J Hematol Oncol Stem Cell Res; 2017 Jul; 11(3):225-230. PubMed ID: 28989589
[No Abstract] [Full Text] [Related]
12. TET2: A cornerstone in normal and malignant hematopoiesis.
Kunimoto H; Nakajima H
Cancer Sci; 2021 Jan; 112(1):31-40. PubMed ID: 33048426
[TBL] [Abstract][Full Text] [Related]
13. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
[TBL] [Abstract][Full Text] [Related]
14. Familial myeloid malignancies with germline TET2 mutation.
Duployez N; Goursaud L; Fenwarth L; Bories C; Marceau-Renaut A; Boyer T; Fournier E; Nibourel O; Roche-Lestienne C; Huet G; Beauvais D; Berthon C; Cambier N; Quesnel B; Preudhomme C
Leukemia; 2020 May; 34(5):1450-1453. PubMed ID: 31827242
[No Abstract] [Full Text] [Related]
15. TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma.
Pierscianek D; Teuber-Hanselmann S; Ahmadipour Y; Darkwah Oppong M; Unteroberdörster M; Müller O; Jabbarli R; Sure U; Zhu Y; El Hindy N
Neuropathology; 2020 Apr; 40(2):138-143. PubMed ID: 31777116
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
